Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Analyst Moves: EMR, CLF

Forbes - 20 Nov 2012 18:51
Emerson (EMR) was downgraded by Oppenheimer (OPY) to outperform from perform with a price target of $53 due to a lack of catalysts to drive the price higher in the near term
Full Article at Forbes

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard